📰 Technology Research Network News
Page 2 - Technology Research Network News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Technology Research Network. Real-time updates on events, politics, business and more.
May 3, 2021
Northwestern spinoff receives $21.3M from NIH to manufacture COVID-19 test Highly sensitive PCR test takes 15 minutes, using cereal box-sized device A user inserts a small cartridge, holding a nasal swab sample, into a DASH system. A new, highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received $21.3 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx SM) initiative. Developed at Northwestern University’s�...
April 29, 2021
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort Share: Insights, lessons learned after a year of transforming COVID-19 testing—a special journal issue One-year into implementation of the National Institutes of Health’s Rapid Acceleration of Diagnostics (RADx) initiative, the Institute of Electrical and Electronics E...
March 1, 2021
HIN A research team funded by the National Institutes of Health has launched a study to assess performance and usability of a smartphone app paired with the Quidel QuickVue At-Home COVID-19 Test, which just received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for use with a prescription. The home test was supported by NIH through the Rapid Acceleration of Diagnostics (RADx) initiative, which has spurred the development and commercial availability of millions ...
February 3, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the ... Meridian Bioscience Inc.February 3, 2021 GMT CINCINNATI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it will increase production capacity of the company’s SARS-CoV-2 molecular diagn...
February 3, 2021
Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown February 03, 2021 10:30 ET | Source: Meridian Bioscience Inc. Meridian Bioscience Inc. Cincinnati, Ohio, UNITED STATES CINCINNATI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it will increase production capacity of th...
December 28, 2020
Share this article Share this article BETHESDA, Maryland., Dec. 28, 2020 /PRNewswire-HISPANIC PR WIRE/ -- The National Institutes of Health has awarded eight research grants to develop approaches for identifying children at high risk for Multisystem Inflammatory Syndrome in Children (MIS-C), a rare and severe after-effect of COVID-19 or exposure to the virus that causes it. Up to $20 million will be provided for the projects over four years, pending the availability of funds. "These awards und...
December 21, 2020
NIH to support radical approaches to nationwide COVID-19 testing and surveillance RADx-rad program will fund non-traditional and repurposed technologies to combat the current pandemic and address future viral disease outbreaks. The National Institutes of Health has awarded over $107 million to support new, non-traditional approaches and reimagined uses of existing tools to address gaps in COVID-19 testing and surveillance. The program also will develop platforms that can be deployed in future o...
December 21, 2020
Awards part of a larger effort to study pediatric COVID-19 and related conditions. The National Institutes of Health has awarded eight research grants to develop approaches for identifying children at high risk for Multisystem Inflammatory Syndrome in Children (MIS-C), a rare and severe after-effect of COVID-19 or exposure to the virus that causes it. Up to $20 million will be provided for the projects over four years, pending the availability of funds. “These awards underscore NIH’s commit...